|
| 36351210 | Resistance Mechanisms to Anti-Epidermal Growth Factor Receptor Therapy in <i>RAS/RAF</i> Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy. | J Clin Oncol | 2023 |
| 37487150 | Transcriptional Profiling and Consensus Molecular Subtype Assignment to Understand Response and Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Colorectal Cancer. | JCO Precis Oncol | 2023 |
| 37738316 | Taxane-Based Chemotherapy Is Effective in Metastatic Appendiceal Adenocarcinoma. | Oncologist | 2023 |
| 37609177 | Impact of <i>KRAS</i> Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma. | Res Sq | 2023 |
| 36993681 | Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma. | bioRxiv | 2023 |
| 37433032 | Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal Adenocarcinoma. | Cancer Res | 2023 |
| 37261831 | Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial. | JAMA Netw Open | 2023 |
| 36853519 | Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasms. | Langenbecks Arch Surg | 2023 |
| 36781990 | Survival improvement for patients with metastatic colorectal cancer over twenty years. | NPJ Precis Oncol | 2023 |
| 35108036 | Clinical and Molecular Characterization of <i>POLE</i> Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers. | JCO Precis Oncol | 2022 |
| 35508177 | Patient-derived micro-organospheres enable clinical precision oncology. | Cell Stem Cell | 2022 |
| 35697807 | Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. | Nat Biotechnol | 2022 |
| 36239938 | Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer. | JAMA Netw Open | 2022 |
| 36382087 | Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer. | Cancer Res Commun | 2022 |
| 35879396 | Oncogene addiction to GNAS in GNAS<sup>R201</sup> mutant tumors. | Oncogene | 2022 |
| 35307803 | What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers? | Ann Surg Oncol | 2022 |
| 35022962 | Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective. | Cancer Metastasis Rev | 2022 |
| 33414133 | ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. | Clin Cancer Res | 2021 |
| 34881776 | Artificial intelligence, molecular subtyping, biomarkers, and precision oncology. | Emerg Top Life Sci | 2021 |
| 34378358 | Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF-PU.1-DPP4 Axis. | Adv Sci (Weinh) | 2021 |
| 34638407 | Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer. | Cancers (Basel) | 2021 |
| 34223192 | Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients. | Nat Cancer | 2021 |
| 34250391 | Comprehensive Clinical and Molecular Characterization of <i>KRAS</i> <sup>G12C</sup>-Mutant Colorectal Cancer. | JCO Precis Oncol | 2021 |
| 34367949 | The Provocative Roles of Platelets in Liver Disease and Cancer. | Front Oncol | 2021 |
| 32545271 | Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract. | Genes (Basel) | 2020 |
| 33037839 | Regarding Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers. | Oncologist | 2020 |
| 32733093 | Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer. | Br J Cancer | 2020 |
| 30718357 | Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer. | Cancer Res | 2019 |
| 31767022 | Lamotrigine-induced hemophagocytic lymphohistiocytosis with Takotsubo cardiomyopathy: a case report. | J Med Case Rep | 2019 |
| 31602605 | Ultrahigh-Density Screens for Genome-Wide Yeast EMAPs in a Single Plate. | Methods Mol Biol | 2019 |
| 29610481 | A global transcriptional network connecting noncoding mutations to changes in tumor gene expression. | Nat Genet | 2018 |
| 32913983 | Genomic Landscape of Appendiceal Neoplasms. | JCO Precis Oncol | 2018 |
| 32913982 | Genomic and Proteomic Alterations in Desmoplastic Small Round Blue-Cell Tumors. | JCO Precis Oncol | 2018 |
| 29932943 | Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls. | J Mol Biol | 2018 |
| 30297789 | Typing tumors using pathways selected by somatic evolution. | Nat Commun | 2018 |
| 29636367 | Disruption of <i>NSD1</i> in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation. | Mol Cancer Ther | 2018 |
| 29186130 | Correcting CRISPR for copy number. | Nat Genet | 2017 |
| 28481362 | Genetic interaction mapping in mammalian cells using CRISPR interference. | Nat Methods | 2017 |
| 28319113 | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | Nat Methods | 2017 |
| 27096704 | Synthesis of Eupalinilide E, a Promoter of Human Hematopoietic Stem and Progenitor Cell Expansion. | J Am Chem Soc | 2016 |
| 27453043 | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. | Mol Cell | 2016 |
| 26083491 | ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer. | PLoS One | 2015 |
| 26437225 | Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition. | Oncotarget | 2015 |
| 25086664 | Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. | Nat Genet | 2014 |
| 24037242 | Network-based stratification of tumor mutations. | Nat Methods | 2013 |
| 20616024 | Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. | Proc Natl Acad Sci U S A | 2010 |
| 16720270 | A robust small-molecule microarray platform for screening cell lysates. | Chem Biol | 2006 |